"Kootenai Clinic is a network of doctors, nurse practitioners and physician assistants who are employed by Kootenai Health and provide care to patients throughout the Inland Northwest."

During the past decade, North Idaho Cancer Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "North Idaho Cancer Center" #1 sponsor was "NSABP Foundation Inc" with 5 trials, followed by "Accelerated Community Oncology Research Network" with 3 trials sponsored, "SWOG Cancer Research Network" with 2 trials sponsored, "Favrille" with 1 trials sponsored and "Genentech, Inc." with 1 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "North Idaho Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 7 trials as a collaborator, "Bayer" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Celgene Corporation" with 1 trials as a collaborator and "Eastern Cooperative Oncology Group" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "North Idaho Cancer Center" are "Breast Cancer" (6 trials), "Colonic Neoplasms" (2 trials), "Colorectal Cancer" (2 trials), "Colorectal Neoplasms" (2 trials) and "Lung Cancer" (2 trials). Many other conditions were trialed in "North Idaho Cancer Center" in a lesser frequency.

Most popular intervention types in "North Idaho Cancer Center" are "Drug" (18 trials), "Biological" (5 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "cyclophosphamide" (3 trials), "Tamoxifen" (2 trials), "Vatalanib" (2 trials) and "doxorubicin" (2 trials). Other intervention names were less common.

The vast majority of trials in "North Idaho Cancer Center" are 11 trials for "All" genders and 9 trials for "Female" genders.

Currently, there are NaN active trials in "North Idaho Cancer Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in North Idaho Cancer Center, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in North Idaho Cancer Center, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".